Human Activated T Lymphocytes Modulate IDO Expression in Tumors through Th1/Th2 Balance
- 15 December 2009
- journal article
- research article
- Published by The American Association of Immunologists in The Journal of Immunology
- Vol. 183 (12), 7752-7760
- https://doi.org/10.4049/jimmunol.0901004
Abstract
Previous cancer vaccination approaches have shown some efficiency in generating measurable immune responses, but they have rarely led to tumor regression. It is therefore possible that tumors emerge with the capacity to down-regulate immune counterparts, through the local production of immunosuppressive molecules, such as IDO. Although it is known that IDO exerts suppressive effects on T cell functions, the mechanisms of IDO regulation in tumor cells remain to be characterized. Here, we demonstrate that activated T cells can induce functional IDO expression in breast and kidney tumor cell lines, and that this is partly attributable to IFN-γ. Moreover, we found that IL-13, a Th2 cytokine, has a negative modulatory effect on IDO expression. Furthermore, we report IDO expression in the majority of breast and kidney carcinoma samples, with infiltration of activated Th1-polarized T cells in human tumors. These findings demonstrate complex control of immune activity within tumors. Future immune therapeutic interventions should thus include strategies to counteract these negative mechanisms.This publication has 51 references indexed in Scilit:
- Molecular and Structural Basis of Cytokine Receptor Pleiotropy in the Interleukin-4/13 SystemCell, 2008
- Plasmacytoid dendritic cells from mouse tumor-draining lymph nodes directly activate mature Tregs via indoleamine 2,3-dioxygenaseJCI Insight, 2007
- IFN‐γ‐induced IDO and WRS expression in microglia is differentially regulated by IL‐4Glia, 2007
- Indoleamine 2,3-dioxygenase and tumor-induced toleranceJCI Insight, 2007
- Breast cancer instructs dendritic cells to prime interleukin 13–secreting CD4+ T cells that facilitate tumor developmentThe Journal of Experimental Medicine, 2007
- Proteasome-Independent Major Histocompatibility Complex Class I Cross-Presentation Mediated by Papaya Mosaic Virus-Like Particles Leads to Expansion of Specific Human T CellsJournal of Virology, 2007
- Indoleamine 2,3-dioxygenase is a novel prognostic indicator for endometrial cancerBritish Journal of Cancer, 2006
- Type, Density, and Location of Immune Cells Within Human Colorectal Tumors Predict Clinical OutcomeScience, 2006
- Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase–mediated tryptophan degradationBlood, 2004
- A new mathematical model for relative quantification in real-time RT-PCRNucleic Acids Research, 2001